Children's Hospital London Health Sciences Centre (LHSC)

London, Ontario N6A4G5

1 studies enrolling now · 3 studies all time

What they study most

Congenital Myotonic Dystrophy, Duchenne Muscular Dystrophy

Studies at this site

• Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy — Recruiting now
• Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy — Completed
• Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment — Stopped early